← 返回

间质 TIL(肿瘤浸润淋巴细胞)(sTILs)作为卵巢癌新辅助化疗后的预后生物标志物

英文原题:Stromal Tumor infiltrating lymphocytes (sTILs) as a prognostic biomarker in Ovarian Cancer After Neoadjuvant chemotherapy.

查看英文原题

Stromal Tumor infiltrating lymphocytes (sTILs) as a prognostic biomarker in Ovarian Cancer After Neoadjuvant chemotherapy.

PubMed 2025/11/22(内容时间) Eur J Surg Oncol Q1 · IF 3.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

尽管我们的研究为 sTILs 在晚期高级别浆液性上皮性卵巢癌中的预后作用提供了一些证据,但所确定的 cut-off 阈值仍需在未来的研究中进一步验证。

研究思路结论见上方概要

本研究旨在评估sTILs对特定高grade浆液性上皮性卵巢癌患者队列中间隔减瘤手术联合HIPEC后生存的预后影响。材料与方法:由专职肿瘤病理学家对168例接受间隔减瘤手术的高grade浆液性卵巢癌患者的福尔马林固定、石蜡包埋(FFPE)肿瘤组织进行评估。计算每位患者卵巢和网膜的平均间质TIL百分比。为确定卵巢癌中TILs可作为预后生物标志物验证参考值的阈值,我们应用了来自R-stats的maxstat包中的最大分布秩统计量。总生存期是衡量预后的终点。TILs对生存的预后显著性通过单变量log rank检验和多变量cox回归分析确定。

卵巢中 sTILS 的组内系数为 0.882 [95 %CI 0.85-0.90],大网膜中 sTILs 的组内系数为 0.93 [95 %CI 0.91-0.95],表明病理学家之间具有良好的观察者间一致性。sTILS 的阈值在卵巢中为 20 %,在大网膜中为 26 %。以 20 % 为截断值分组的卵巢 sTILS 在单变量和多变量分析中均显示总生存期(OS)改善。(Log rank 0.97(0.94-0.99,p = 0.007),cox 回归分析分别为 [HR 0.96(95 %CI 0.93-0.99,p = 0.003)]。

展开英文摘要原文

The aim of the study was to evaluate the prognostic impact of sTILs on survival in a specific cohort of patients of high grade serous epithelial ovarian cancer following interval cytoreductive surgery HIPEC. MATERIAL AND METHOD: Formalin fixed, paraffin embedded (FFPE) tumor tissue of high grade serous ovarian cancer of 168 patients, undergoing interval cytoreductive surgery were evaluated by dedicated oncopathologists. The average stromal TIL percentage was calculated for each patient, for ovary and omentum. To determine a threshold for TILS in Ovarian cancer which can serve as a reference value for validation as a prognostic biomarker, we applied maximally distributed rank statistics using the 'maxstat' package from 'R-stats'. Overall survival was the endpoint for measuring prognosis. The prognostic significant of TILs on survival was determined using univariable log rank test and multivariable cox-regression analysis. RESULT: The Intraclass coefficient for sTILS in the ovary was 0.882 [95 %CI 0.85-0.90] and 0.93 for sTILs in the omentum was 0.93 [95 %CI 0.91-0.95] showing that there was good interobserver agreement between the pathologist. Threshold for sTILS was 20 % for the ovary and 26 % for the omentum. sTILS in the ovary separated by the cut-off 20 %, showed an improvement in overall survival (OS) in both univariate as well as multivariate analysis. (Log rank 0.97 (0.94-0.99, p = 0.007), cox regression analysis, [HR 0.96 (95 %CI 0.93-0.99, p = 0.003) ] respectively.

While our study provides some evidence for the prognostic role of sTILs in advanced high-grade serous epithelial ovarian cancer, the determined cut-off threshold warrants additional validation in future studies.

论文信息

作者
Sinukumar S、Kazi M、Jumle N、Kumar LS、Damodaran D、Pv S、C S、Trivedi M
第一作者单位
Dept. of Surgical Oncology, Jehangir Hospital, 32, Sassoon Road, Pune, Maharashtra, India. Electronic address: snitanag@gmail.com.India
通讯作者单位
Shalby Hospital, Ahmedabad, Gujarat, India. Electronic address: aditimodi31@gmail.com.India
期刊
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology2026 Jan
原文标识
PubMed 41308398 · DOI 10.1016/j.ejso.2025.111193